New Hope For Pediatric Leukemia Patients

Cincinnati Children’s Hospital Medical Center will soon be getting a newly-approved drug that uses the body’s own immune system to fight cancer.

Kymriah, also known as CAR T-cell therapy, takes a patient’s own immune cells and reprograms them to fight acute lymphocytic leukemia (ALL).

To find out how the drug is providing new hope for leukemia patients, click on WVXU.

 

Topics:

Cincinnati Children's News Team

About the Author: Cincinnati Children's News Team

The members of the news team at Cincinnati Children's are responsible for telling the stories of the medical center. Stories of the families we serve, research and clinical care, safe and healthy practices and happenings at the hospital. If it has to do with Cincinnati Children's, Danielle, Nick, Jim, Kate, Rachel, Terry and Shannon will keep you informed.

Write a comment

Your data will be safe! Your e-mail address will not be published. Also other data will not be shared with third person. Required fields marked as *

Comments

No Comments Yet! You can be first to comment on this post!